Our website is set to allow the use of cookies. For more information and to change settings click here. If you are happy with cookies please click "Continue" or simply continue browsing. Continue.

Competition Law

Analysis - debate - current awareness

08 JAN 2013

Off-Patent Abuses in the Pharmaceutical Sector

This article examines a range of potentially abusive behaviour by dominant pharmaceutical manufacturers. Abuse of the patent system can take a number of forms and two in particular are identified: (i) abusive extension of the period of patent protection; and (ii) abusive withdrawal of marketing authorisations and products. The article draws out the circumstances in which such behaviour might arise, examines its effects and considers the extent to which it may be objectively justified. In addition, the article analyses a number of recent decisions in which challenges have been brought against pharmaceutical manufacturers who have refused to supply drugs albeit where such refusals are sought to be justified along the lines envisaged in the recent GlaxoSmithKline decision which is also discussed.

Brendan McGurk

Law of Cartels

Law of Cartels

Provides practical advice and guidance on dealing with cartel law

UK Competition Law Reports

UK Competition Law Reports

A comprehensive service which brings together the case-law of the Competition Appeal Tribunal,...

More Info from £175.00
Available in Lexis®Library